The effect of ranibizumab and aflibercept treatment on the prevalence of outer retinal tubulation and its influence on retreatment in neovascular age-related macular degeneration

被引：0
|
作者：
Attila Kovacs
Timea Kiss
Ferenc Rarosi
Gabor M. Somfai
Andrea Facsko
Rozsa Degi
机构：
[1] University of Szeged,Department of Ophthalmology, Faculty of Medicine
[2] University of Szeged,Department of Medical Physics and Informatics, Faculty of Medicine
[3] Augenzentrum Pallas Kliniken,Department of Ophthalmology, Faculty of Medicine
[4] Semmelweis University,undefined
来源：
BMC Ophthalmology | / 18卷
关键词：
Outer retinal tubulation; Prevalence; Anti-VEGF; Aflibercept; Retreatment; Subretinal hyperreflective material;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Retinal metabolic and structural alterations in response to aflibercept treatment in neovascular age-related macular degeneration
    Jakobsen, Ditte B.
    Torp, Thomas L.
    Stefansson, Einar
    Peto, Tunde
    Grauslund, Jakob
    ACTA OPHTHALMOLOGICA, 2019, 97 (05) : 525 - 531
  • [42] Bimonthly Ranibizumab for Neovascular Age-Related Macular Degeneration
    Cohen, Salomon Yves
    Maloberti, Bertrand
    Fajnkuchen, Franck
    Nghiem-Buffet, Sylvia
    Delahaye-Mazza, Corinne
    Grenet, Typhaine
    Quentel, Gabriel
    OPHTHALMOLOGICA, 2014, 231 (02) : 80 - 85
  • [43] Ranibizumab for neovascular age-related macular degeneration - Reply
    Rosenfeld, Philip J.
    Brown, David M.
    Schneider, Susan
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (07): : 749 - 750
  • [44] Retinal Pigment Epithelial Atrophy in Neovascular Age-Related Macular Degeneration After Ranibizumab Treatment
    Kuroda, Yoshimasa
    Yamashiro, Kenji
    Tsujikawa, Akitaka
    Ooto, Sotaro
    Tamura, Hiroshi
    Oishi, Akio
    Nakanishi, Hideo
    Miyake, Masahiro
    Yoshikawa, Munemitsu
    Yoshimura, Nagahisa
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2016, 161 : 94 - 103
  • [45] Pharmacogenetic Studies of Ranibizumab Treatment in Neovascular Age-Related Macular Degeneration
    Den Hollander, A. I.
    Smailhodzic, D.
    Khan, H. A.
    Omar, A.
    Zhang, A. Y.
    Kirchhof, B.
    Chen, J.
    Hoyng, C. B.
    Koenekoop, R. K.
    Fauser, S.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [46] Comparison of Time to Retreatment and Visual Function Between Ranibizumab and Aflibercept in Age-Related Macular Degeneration
    Inoue, Maiko
    Yamane, Shin
    Sato, Shimpei
    Sakamaki, Kentaro
    Arakawa, Akira
    Kadonosono, Kazuaki
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2016, 169 : 95 - 103
  • [47] Evaluation of outer retinal tubulations in eyes switched from intravitreal ranibizumab to aflibercept for treatment of exudative age-related macular degeneration
    Massamba, Nathalie
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [48] Comparison of Time to Retreatment and Visual Function Between Ranibizumab and Aflibercept in Age-Related Macular Degeneration
    Calugaru, Dan
    Calugaru, Mihai
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2017, 174 : 181 - 182
  • [49] Ranibizumab versus bevacizumab for the treatment of neovascular age-related macular degeneration
    Abouammoh, Marwan
    Sharma, Sanjay
    CURRENT OPINION IN OPHTHALMOLOGY, 2011, 22 (03) : 152 - 158
  • [50] Evaluation of outer retinal tubulations in eyes switched from intravitreal ranibizumab to aflibercept for treatment of exudative age-related macular degeneration
    Nathalie Massamba
    Ali Dirani
    Nathalie Butel
    Christine Fardeau
    Bahram Bodaghi
    April Ingram
    Phuc Lehoang
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2017, 255 : 61 - 67
12345